Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bowser

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
Annals of Neurology|February 1, 2021
To Zoom or Not to Zoom: The Should I Travel Index Revisited during the Coronavirus Disease PandemicSeward B Rutkove, Jeremy M Shefner, Robert Bowser, et al.
The Journal of Biological Chemistry|April 20, 2006
Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cellsElisabeth M Chalovich, Jian-hui Zhu, John Caltagarone, et al.
Journal of Alzheimer'S Disease : JAD|April 30, 2003
Von Willebrand factor promoter targets the expression of amyloid beta protein precursor to brain vascular endothelial cells of transgenic miceNadia Jahroudi, Alvin Schmaier, Sujata Srikanth, et al.
Cellular and Molecular Life Sciences : CMLS|July 19, 2013
Therapeutic neuroprotective agents for amyotrophic lateral sclerosisRachna S Pandya, Haining Zhu, Wei Li, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 7, 2010
Proposed BioRepository platform solution for the ALS research communityAlex Sherman, Robert Bowser, Daniela Grasso, et al.
Frontiers in Bioengineering and Biotechnology|April 16, 2020
Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1<sup>G93A</sup> Mouse Model of ALSDavid X Medina, Eugene P Chung, Collin D Teague, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2010
Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in control and Alzheimer disease hippocampiJohn Caltagarone, Ronald L Hamilton, Geoffrey Murdoch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 5, 2023
Effect of sodium phenylbutyrate and taurursodiol on plasma concentrations of neuroinflammatory biomarkers in amyotrophic lateral sclerosis: results from the CENTAUR trialRobert Bowser, Jiyan An, Lahar Mehta, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 22, 2019
Neurofilaments in pre-symptomatic ALS and the impact of genotypeMichael Benatar, Joanne Wuu, Vittoria Lombardi, et al.
Nature Communications|January 7, 2023
Molecular subtypes of ALS are associated with differences in patient prognosisJarrett Eshima, Samantha A O'Connor, Ethan Marschall, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
Annals of Neurology|February 1, 2021
To Zoom or Not to Zoom: The Should I Travel Index Revisited during the Coronavirus Disease PandemicSeward B Rutkove, Jeremy M Shefner, Robert Bowser, et al.
The Journal of Biological Chemistry|April 20, 2006
Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cellsElisabeth M Chalovich, Jian-hui Zhu, John Caltagarone, et al.
Journal of Alzheimer'S Disease : JAD|April 30, 2003
Von Willebrand factor promoter targets the expression of amyloid beta protein precursor to brain vascular endothelial cells of transgenic miceNadia Jahroudi, Alvin Schmaier, Sujata Srikanth, et al.
Cellular and Molecular Life Sciences : CMLS|July 19, 2013
Therapeutic neuroprotective agents for amyotrophic lateral sclerosisRachna S Pandya, Haining Zhu, Wei Li, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 7, 2010
Proposed BioRepository platform solution for the ALS research communityAlex Sherman, Robert Bowser, Daniela Grasso, et al.
Frontiers in Bioengineering and Biotechnology|April 16, 2020
Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1<sup>G93A</sup> Mouse Model of ALSDavid X Medina, Eugene P Chung, Collin D Teague, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2010
Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in control and Alzheimer disease hippocampiJohn Caltagarone, Ronald L Hamilton, Geoffrey Murdoch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 5, 2023
Effect of sodium phenylbutyrate and taurursodiol on plasma concentrations of neuroinflammatory biomarkers in amyotrophic lateral sclerosis: results from the CENTAUR trialRobert Bowser, Jiyan An, Lahar Mehta, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 22, 2019
Neurofilaments in pre-symptomatic ALS and the impact of genotypeMichael Benatar, Joanne Wuu, Vittoria Lombardi, et al.
Nature Communications|January 7, 2023
Molecular subtypes of ALS are associated with differences in patient prognosisJarrett Eshima, Samantha A O'Connor, Ethan Marschall, et al.
Pageof 15